Publications We at SKC have a profound knowledge of the health care industry and want to share our valuable experience with you.
Publication Orphan drugs after GSAV Are fulfilled obligations more satisfying than exercised rights? more
Publication Orphan drugs in Germany Lessons learned from AMNOG, best and worst practices and strategic implications more
Strategy Report Successful market access for gene … New strategic challenges and possible solutions more
